亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

隨州市紅旗化工有限公司  

醫藥原料醫藥中間體原料藥

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:閆先生
  • 電話:0722-3257386
  • 傳真:0722-3257381
  • QQ:1374834438
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 三磷酸腺苷二鈉CAS號: 51963-61-2
三磷酸腺苷二鈉CAS號: 51963-61-2
單價 面議對比
詢價 暫無
發貨 湖北隨州市付款后3天內
型號 51963-61-2
過期 長期有效
更新 2020-06-18 10:08
 
詳細信息


三磷酸腺苷二鈉
CAS號: 51963-61-2
中文同義詞: 5'-三磷酸腺苷二鈉鹽;腺貳三磷酸二鈉;磷酸腺甙鈉;磷酸腺苷鈉;三磷酸腺苷二鈉;腺嘌呤核苷-5'-三磷酸酯二鈉鹽;三磷酸腺甙;三磷酸腺苷鈉
英文名稱: Adenosine 5'-triphosphate disodium salt
英文同義詞: adenosine-5-triphosphatedisodiumsigmagrade;Disodiumadenosine5’-triphosphatetrihydrate;ATP TETRASODIUM SALT;ADENOSINE 5'-TRIPHOSPHATE TETRASODIUM;ADENOSINE 5'-TRIPHOSPHATE, TETRASODIUM SALT;ADENOSIN-5'-TRIPHOSPHATE TETRASODIUM SALT;adenosine disodium 5-triphosphate;5'-ATP-Na2
分子式: C10H14N5Na2O13P3
分子量: 551.15
EINECS號: 213-579-1
熔點  176°C
標準:cp2005
含量;≥95.0%
性狀:本品為白色結晶或類白色粉末,無臭,略有酸味;有引濕性。
用途  輔助酶類藥,用于進行性肌萎縮、腦溢血后遺癥、心功能不全、心肌疾患及肝炎等癥的治療
包裝:25kg/桶

©2025 隨州市紅旗化工有限公司 版權所有   技術支持:化工網   訪問量:31230  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |